Fig. 4
From: Afrormosin exerts an anticancer effect via MAPK and AKT signaling pathways in B16F10 cells
The effects of afrormosin on cell cycle in B16F10 melanoma cells. The cell cycle was measured by flow cytometry. A The histogram shows the cell cycle phase of B16F10 cells following treatment with 100 μM afrormosin for 72 h. B, C The bar graph shows the percentage of each cell cycle phase. **p < 0.01 and ***p < 0.001 when compared with the control group. The data are presented as the means ± SD; n = 3